These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1737532)

  • 1. Glutamate decarboxylase: an autoantigen in IDDM.
    Clare-Salzler MJ; Tobin AJ; Kaufman DL
    Diabetes Care; 1992 Jan; 15(1):132-5. PubMed ID: 1737532
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant glutamic acid decarboxylase (representing the single isoform expressed in human islets) detects IDDM-associated 64,000-M(r) autoantibodies.
    Karlsen AE; Hagopian WA; Petersen JS; Boel E; Dyrberg T; Grubin CE; Michelsen BK; Madsen OD; Lernmark A
    Diabetes; 1992 Oct; 41(10):1355-9. PubMed ID: 1397711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Islet cell autoantigens in type 1 diabetes.
    Christie MR
    Eur J Clin Invest; 1996 Oct; 26(10):827-38. PubMed ID: 8911854
    [No Abstract]   [Full Text] [Related]  

  • 4. High prevalence of autoantibodies to glutamic acid decarboxylase in long-standing IDDM is not a marker of symptomatic autonomic neuropathy.
    Zanone MM; Petersen JS; Peakman M; Mathias CJ; Watkins PJ; Dyrberg T; Vergani D
    Diabetes; 1994 Sep; 43(9):1146-51. PubMed ID: 8070615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase.
    Baekkeskov S; Aanstoot HJ; Christgau S; Reetz A; Solimena M; Cascalho M; Folli F; Richter-Olesen H; De Camilli P
    Nature; 1990 Sep; 347(6289):151-6. PubMed ID: 1697648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitive monoclonal antibody-based sandwich ELISA for determination of the diabetes-associated autoantigen glutamic acid decarboxylase GAD65.
    Schlosser M; Hahmann J; Ziegler B; Augstein P; Ziegler M
    J Immunoassay; 1997 Nov; 18(4):289-307. PubMed ID: 9358337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase.
    Myers MA; Rabin DU; Rowley MJ
    Diabetes; 1995 Nov; 44(11):1290-5. PubMed ID: 7589826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of GAD65 and IA-2 autoantibodies in IDDM patients affected by diabetic nephropathy.
    Zerbini G; Bazzigaluppi E; Mangili R; Bosi E; Bonifacio E
    Diabetologia; 1997 Apr; 40(4):485. PubMed ID: 9112029
    [No Abstract]   [Full Text] [Related]  

  • 9. Persistent GAD 65 antibodies in longstanding IDDM are not associated with residual beta-cell function, neuropathy or HLA-DR status.
    Jaeger C; Allendörfer J; Hatziagelaki E; Dyrberg T; Bergis KH; Federlin K; Bretzel RG
    Horm Metab Res; 1997 Oct; 29(10):510-5. PubMed ID: 9405979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-lymphocyte lines specific for glutamic acid decarboxylase (GAD) the 64K beta-cell antigen of IDDM.
    Diaz JL; Ways J; Hammonds P
    Diabetes; 1992 Jan; 41(1):118-21. PubMed ID: 1727731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies.
    Bonifacio E; Lampasona V; Genovese S; Ferrari M; Bosi E
    J Immunol; 1995 Dec; 155(11):5419-26. PubMed ID: 7594559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune reactivity of diabetes-associated human monoclonal autoantibodies defines multiple epitopes and detects two domain boundaries in glutamate decarboxylase.
    Syren K; Lindsay L; Stoehrer B; Jury K; Lühder F; Baekkeskov S; Richter W
    J Immunol; 1996 Dec; 157(11):5208-14. PubMed ID: 8943434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The glutamate decarboxylase and 38KD autoantigens in type 1 diabetes: aspects of structure and epitope recognition.
    Baekkeskov S; Aanstoot HJ; Fu Q; Jaffe M; Kim J; Quan J; Richter W; Shi Y
    Autoimmunity; 1993; 15 Suppl():24-6. PubMed ID: 7692998
    [No Abstract]   [Full Text] [Related]  

  • 14. No association of antibodies to glutamic acid decarboxylase and diabetic complications in patients with IDDM.
    Roll U; Nuber A; Schröder A; Gerlach E; Janka HU; Ziegler AG
    Diabetes Care; 1995 Feb; 18(2):210-5. PubMed ID: 7729299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. The DENIS Study Group. Deutsche Nikotinamid Interventions-Studie.
    Seissler J; Morgenthaler NG; Achenbach P; Lampeter EF; Glawe D; Payton M; Christie M; Scherbaum WA
    Diabetologia; 1996 Nov; 39(11):1351-6. PubMed ID: 8933004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus.
    Kaufman DL; Erlander MG; Clare-Salzler M; Atkinson MA; Maclaren NK; Tobin AJ
    J Clin Invest; 1992 Jan; 89(1):283-92. PubMed ID: 1370298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persisting antibodies to glutamic acid decarboxylase in type 1 (insulin-dependent) diabetes mellitus are not associated with neuropathy.
    Tuomi T; Zimmet PZ; Rowley MJ; Serjeantson SW; Mackay IR
    Diabetologia; 1993 Jul; 36(7):685. PubMed ID: 8359590
    [No Abstract]   [Full Text] [Related]  

  • 18. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
    Whittingham S; Byron SL; Tuomilehto J; Zimmet PZ; Myers MA; Vidgren G; Rowley MJ; Feeney SJ; Koskela P; Tuomilehto-Wolf E; Mackay IR
    Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GAD, a single autoantigen for diabetes.
    von Boehmer H; Sarukhan A
    Science; 1999 May; 284(5417):1135, 1137. PubMed ID: 10366347
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus.
    Bingley PJ; Bonifacio E; Gale EA
    Lancet; 1994 Jul; 344(8917):266-7. PubMed ID: 7913179
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.